If you notice, we're behind the target date as well on this trial!
Study start date
The actual date on which the first participant was enrolled in a clinical study. The "estimated" study start date is the date that the researchers think will be the study start date.
Apabetalone for Pulmonary Arterial Hypertension (APPROACH-2)
Recruitment Status : Not yet recruiting
First Posted : June 7, 2021
Last Update Posted : June 7, 2021
|
Study Type :
|
Interventional (Clinical Trial) |
| Estimated Enrollment : |
72 participants |
| Allocation: |
Randomized |
| Intervention Model: |
Parallel Assignment |
| Intervention Model Description: |
Randomized, double-blind, placebo-controlled study |
| Masking: |
Double (Participant, Investigator) |
| Primary Purpose: |
Treatment |
| Official Title: |
Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study |
| Estimated Study Start Date : |
July 2021 |
| Estimated Primary Completion Date : |
March 2024 |
| Estimated Study Completion Date : |
March 2025 |
https://clinicaltrials.gov/ct2/show/NCT04915300?spons=resverlogix&draw=3&rank=12
